Sriram Ryali - Net Worth and Insider Trading
Sriram Ryali Net Worth
The estimated net worth of Sriram Ryali is at least $627,752 dollars as of 2024-12-28. Sriram Ryali is the CFO of Codexis Inc and owns about 123,441 shares of Codexis Inc (CDXS) stock worth over $615,971. Sriram Ryali is also the CFO of Eiger BioPharmaceuticals Inc and owns about 1,386 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $11,781. Details can be seen in Sriram Ryali's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sriram Ryali has not made any transactions after 2023-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sriram Ryali
Sriram Ryali Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sriram Ryali owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Codexis Inc (CDXS) .
Click here to see the complete history of Sriram Ryali’s form 4 insider trades.
Insider Ownership Summary of Sriram Ryali
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-14 | Chief Financial Officer |
| CDXS | Codexis Inc | 2023-09-08 | Chief Financial Officer |
Sriram Ryali Latest Holdings Summary
Sriram Ryali currently owns a total of 2 stocks. Among these stocks, Sriram Ryali owns 123,441 shares of Codexis Inc (CDXS) as of September 8, 2023, with a value of $615,971 and a weighting of 98.12%. Sriram Ryali also owns 1,386 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of March 14, 2022, with a value of $11,781 and a weighting of 1.88%.
Latest Holdings of Sriram Ryali
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDXS | Codexis Inc | 2023-09-08 | 123,441 | 4.99 | 615,971 |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-14 | 1,386 | 8.50 | 11,781 |
Holding Weightings of Sriram Ryali
Sriram Ryali Form 4 Trading Tracker
According to the SEC Form 4 filings, Sriram Ryali has made a total of 1 transactions in Codexis Inc (CDXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Codexis Inc is the acquisition of 11,650 shares on September 8, 2023, which cost Sriram Ryali around $19,805.
According to the SEC Form 4 filings, Sriram Ryali has made a total of 1 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the sale of 76 shares on March 14, 2022, which brought Sriram Ryali around $12,690.
Insider Trading History of Sriram Ryali
- 1
Sriram Ryali Trading Performance
GuruFocus tracks the stock performance after each of Sriram Ryali's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sriram Ryali is 15.23%. GuruFocus also compares Sriram Ryali's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sriram Ryali within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sriram Ryali's insider trading performs compared to the benchmark.
Performance of Sriram Ryali
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.76 | | | | | |
| Relative Return to S&P 500(%) | 14.32 | | | | | |
Sriram Ryali Ownership Network
Sriram Ryali Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Sriram Ryali is the Chief Financial Officer of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, Sriram Ryali made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
Sriram Ryali Mailing Address
Above is the net worth, insider trading, and ownership report for Sriram Ryali. You might contact Sriram Ryali via mailing address: C/o Eiger Biopharmaceuticals, Inc., 2155 Park Blvd., Palo Alto Ca 94306.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
